Analyzing Globin Gene Variation in gnomAD: Implications for Variant Interpretation in Hemoglobinopathies
- 1Blood Disorder Genetics & Thalassemia, The Cyprus Institute of Neurology & Genetics, Iroon Avenue 6, Agios Dometios 2371, Cyprus
Abstract
Given the augmented sampling and ancestry stratification of the Genome Aggregation Database (gnomAD) v4.1 compared with v2.1.1, population evidence for globin gene variants was assessed for changes in fulfillment of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology (ACMG/AMP) criteria, which can alter downstream variant interpretation. Variants and constraint metrics for α-globin locus genes HBA1, HBA2, and HBZ, and β-globin locus genes HBB, HBD, HBG1, HBG2, and HBE1, were extracted from gnomAD v2.1.1 and v4.1 callsets, harmonized, matched to ClinVar annotations, and evaluated for BA1, BS1, BS2, BS2_Supporting, and PM2_Supporting ACMG/AMP criteria fulfillment using Clinical Genome Resource Hemoglobinopathy Variant Curation Expert Panel thresholds. Globin gene variants increased fourfold between gnomAD releases, with HBB accounting for the largest share. In v4.1, 68.7% of quality-passing variants were ancestry-specific, 14.4% overlapped ClinVar and PM2_Supporting fulfillment rose from 81.5% to 93.5%. Among variants present in both releases, ACMG/AMP population-criterion assessments were largely concordant, with conflicting combinations in fewer than 1%. Leveraging augmented sampling and improved ancestry representation, gnomAD v4.1 increased globin gene variant discovery, particularly for rare variants, improving allele frequency estimation and assessment of BA1, BS1, and PM2_Supporting, although criterion fulfillment remains release- and callset-specific.
Related
- From conservation scores to language models: a feature engineering perspective on machine learning for genetic variant interpretation
- Saturation mutagenesis enables RAD51D clinical variant interpretation and identifies distinct biochemical functions
- Diagnostic Yield and Variant Spectrum in 375 Patients with Segmental Overgrowth and Vascular Malformations: Implications for Panel Design and Molecular Testing Strategies
- Protocol for analyzing tumor-infiltrating bystander CD8+ T cells in mice using adoptive transfer of P14 TCR-transgenic CD8+ T cells
- Protocol for imaging and analyzing the synaptic coverage of astrocytes with super-resolution STED microscopy in mouse brain slices
BibTeX
@article{kontopoulou2026analyzing,
title = {{Analyzing Globin Gene Variation in gnomAD: Implications for Variant Interpretation in Hemoglobinopathies}},
author = {Mikaella Kontopoulou and Maria Xenophontos and Carsten Werner Lederer and Coralea Stephanou and Petros Kountouris},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = nov,
doi = {10.3390/ijms272210255},
url = {https://www.mdpi.com/1422-0067/27/22/10255},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Analyzing Globin Gene Variation in gnomAD: Implications for Variant Interpretation in Hemoglobinopathies
AU - Mikaella Kontopoulou
AU - Maria Xenophontos
AU - Carsten Werner Lederer
AU - Coralea Stephanou
AU - Petros Kountouris
PY - 2026
DA - 2026/11/15
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms272210255
UR - https://www.mdpi.com/1422-0067/27/22/10255
AB - Given the augmented sampling and ancestry stratification of the Genome Aggregation Database (gnomAD) v4.1 compared with v2.1.1, population evidence for globin gene variants was assessed for changes in fulfillment of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology (ACMG/AMP) criteria, which can alter downstream variant interpretation. Variants and constraint metrics for α-globin locus genes HBA1, HBA2, and HBZ, and β-globin locus genes HBB, HBD, HBG1, HBG2, and HBE1, were extracted from gnomAD v2.1.1 and v4.1 callsets, harmonized, matched to ClinVar annotations, and evaluated for BA1, BS1, BS2, BS2_Supporting, and PM2_Supporting ACMG/AMP criteria fulfillment using Clinical Genome Resource Hemoglobinopathy Variant Curation Expert Panel thresholds. Globin gene variants increased fourfold between gnomAD releases, with HBB accounting for the largest share. In v4.1, 68.7% of quality-passing variants were ancestry-specific, 14.4% overlapped ClinVar and PM2_Supporting fulfillment rose from 81.5% to 93.5%. Among variants present in both releases, ACMG/AMP population-criterion assessments were largely concordant, with conflicting combinations in fewer than 1%. Leveraging augmented sampling and improved ancestry representation, gnomAD v4.1 increased globin gene variant discovery, particularly for rare variants, improving allele frequency estimation and assessment of BA1, BS1, and PM2_Supporting, although criterion fulfillment remains release- and callset-specific.
SN - 1422-0067
ER -